Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2

Detalles Bibliográficos
Autores principales: Habtemariam, Solomon, Nabavi, Seyed Fazel, Ghavami, Saeid, Cismaru, Cosmin Andrei, Berindan-Neagoe, Ioana, Nabavi, Seyed Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192109/
https://www.ncbi.nlm.nih.gov/pubmed/32360584
http://dx.doi.org/10.1016/j.phrs.2020.104853
_version_ 1783527963280539648
author Habtemariam, Solomon
Nabavi, Seyed Fazel
Ghavami, Saeid
Cismaru, Cosmin Andrei
Berindan-Neagoe, Ioana
Nabavi, Seyed Mohammad
author_facet Habtemariam, Solomon
Nabavi, Seyed Fazel
Ghavami, Saeid
Cismaru, Cosmin Andrei
Berindan-Neagoe, Ioana
Nabavi, Seyed Mohammad
author_sort Habtemariam, Solomon
collection PubMed
description
format Online
Article
Text
id pubmed-7192109
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71921092020-04-30 Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2 Habtemariam, Solomon Nabavi, Seyed Fazel Ghavami, Saeid Cismaru, Cosmin Andrei Berindan-Neagoe, Ioana Nabavi, Seyed Mohammad Pharmacol Res Article Elsevier Ltd. 2020-07 2020-04-30 /pmc/articles/PMC7192109/ /pubmed/32360584 http://dx.doi.org/10.1016/j.phrs.2020.104853 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Habtemariam, Solomon
Nabavi, Seyed Fazel
Ghavami, Saeid
Cismaru, Cosmin Andrei
Berindan-Neagoe, Ioana
Nabavi, Seyed Mohammad
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
title Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
title_full Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
title_fullStr Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
title_full_unstemmed Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
title_short Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
title_sort possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against sars-cov-2 infection based on its action on the transmembrane serine protease 2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192109/
https://www.ncbi.nlm.nih.gov/pubmed/32360584
http://dx.doi.org/10.1016/j.phrs.2020.104853
work_keys_str_mv AT habtemariamsolomon possibleuseofthemucolyticdrugbromhexinehydrochlorideasaprophylacticagentagainstsarscov2infectionbasedonitsactiononthetransmembraneserineprotease2
AT nabaviseyedfazel possibleuseofthemucolyticdrugbromhexinehydrochlorideasaprophylacticagentagainstsarscov2infectionbasedonitsactiononthetransmembraneserineprotease2
AT ghavamisaeid possibleuseofthemucolyticdrugbromhexinehydrochlorideasaprophylacticagentagainstsarscov2infectionbasedonitsactiononthetransmembraneserineprotease2
AT cismarucosminandrei possibleuseofthemucolyticdrugbromhexinehydrochlorideasaprophylacticagentagainstsarscov2infectionbasedonitsactiononthetransmembraneserineprotease2
AT berindanneagoeioana possibleuseofthemucolyticdrugbromhexinehydrochlorideasaprophylacticagentagainstsarscov2infectionbasedonitsactiononthetransmembraneserineprotease2
AT nabaviseyedmohammad possibleuseofthemucolyticdrugbromhexinehydrochlorideasaprophylacticagentagainstsarscov2infectionbasedonitsactiononthetransmembraneserineprotease2

Ejemplares similares